TP53 and gastric cancer: Interestingly, when the spectrum of TP53 mutations was compared between our study and three previous TP53 mutational studies for non-Rwandan patients with gastric cancer, G:C > T:A mutations were significantly more frequent in our study than in the three previous TP53 mutational studies, and even after correction for FDR, statistical significance was observed.